Question: What are the potential advantages of buprenorphine as compared with morphine treatment of neonatal abstinence syndrome?
Answer: One recent study reported: “Among infants with the neonatal abstinence syndrome, treatment with sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than treatment with oral morphine, with similar rates of adverse events.” (Kraft WK. Buprenorphine for the treatment of the neonatal abstinence syndrome. 2017 NEJM published online May 4, 2017, (DOI: 10.1056/NEJMoa1614835)
Posted in Question Of The Day